Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideGILDGilead Sciences
FinDog View：Neutral
REGNRegeneron Pharmaceuticals
FinDog View：Neutral
| Metric | GILD | REGN |
|---|
| Close | 170.68 | 927.89 |
| Market Cap | $213B | $93.4B |
| 1M | +14.51% | +22.37% |
| P/E (TTM) | — | 19.5 |
| Forward P/E | 22.0 | 13.4 |
| P/E 5-Yr Percentile | — | 56 |
| P/S | 7.0 | 5.4 |
| P/B | 17.9 | 2.7 |
| Dividend Yield | 3.98% | 0.45% |
| Latest Quarter Revenue | $8.3B | $5.1B |
| Revenue YoY | +6.8% | +36.3% |
| Gross Margin | 81.1% | — |
| Latest Quarter EPS | 1.94 | 18.45 |
| Avg Post-Earnings Move | ±3.8% | ±1.4% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.57% | 3.66% |
| 90-Day Net Insider Buying | −$15.9M | −$6.5M |
GILD · Revenue, Last 8 Quarters ($B)
REGN · Revenue, Last 8 Quarters ($B)
